EVOME MEDICAL TECHNOLOGIES INC. Annual Deferred Income Tax Expense (Benefit) in CAD from 2020 to 2023

Taxonomy & unit
us-gaap: CAD
Description
Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.
Summary
Evome Medical Technologies Inc. annual/quarterly Deferred Income Tax Expense (Benefit) history and growth rate from 2020 to 2023.
  • Evome Medical Technologies Inc. Deferred Income Tax Expense (Benefit) for the quarter ending March 31, 2023 was CA$0.000.
  • Evome Medical Technologies Inc. Deferred Income Tax Expense (Benefit) for the twelve months ending March 31, 2023 was -CA$193K, a 68.9% decline year-over-year.
  • Evome Medical Technologies Inc. annual Deferred Income Tax Expense (Benefit) for 2023 was CA$0.000.
  • Evome Medical Technologies Inc. annual Deferred Income Tax Expense (Benefit) for 2021 was -CA$114K.
Deferred Income Tax Expense (Benefit), Trailing 12 Months (CAD)
Deferred Income Tax Expense (Benefit), Annual (CAD)
* An asterisk sign (*) next to the value indicates that the value is likely invalid.